TouchBio RSV, Flu A/B and COVID-19 Rapid Antigen Test

In response to the growing concern for co-infections and to help protect vulnerable community members as Australia heads into flu season, Touch Biotechnology has released its TGA-approved multi-virus diagnostic testing kit to the Australian market. The cutting-edge diagnostic solution is designed to empower people to take control of their health by providing a convenient and sensitive test for detecting respiratory syncytial virus (RSV), Flu A/B and COVID-19 infections at home.

The test is said to feature a high sensitivity rate for all three viruses and an accuracy rate of over 98%. Through a single nasal swab, results are available within 15 min, allowing users to obtain timely information about their health status.

Australians are recommended to take the test when they feel unwell, have any symptoms or have been in contact with someone who has these viruses. The test kit will be available to purchase at retail stores and online.